Jumo Health
Jumo Health is a Patient Experience Organization that sells CORE™ patient education content and the patent-pending PRISM™ readiness intelligence platform to biopharma sponsors and research partners, helping them improve clinical trial recruitment, enrollment, and completion.
- Company typePrivate
- Founded2009
- HeadquartersNew Haven, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Jumo Health does
Jumo Health is a private, for-profit Patient Experience Organization founded in 2009 and headquartered in New Haven, Connecticut, that builds readiness-based infrastructure for clinical trial recruitment, enrollment, and retention. The company sells two integrated products: CORE™, a patient education platform that translates protocols into human understanding across the clinical journey, and PRISM™, a patent-pending Patient Readiness & Intelligence System launched in January 2026 that identifies eligible patients with high probability of activation, assesses cognitive readiness, personalizes education via conversational AI, and surfaces real-time readiness, risk, and completion signals. PRISM's AI layer is delivered through a February 2026 strategic partnership with Areti Health, which supplies conversational and agentic AI capabilities for adaptive, governed patient interactions in regulated clinical environments.
Jumo Health operates a B2B enterprise SaaS model with subscription/recurring revenue and quote-based pricing, targeting biopharma sponsors, research sites, and Clinical Operations Leaders responsible for trial timelines and cost-per-completer. GTM is enterprise field sales aimed at executive buyers at large pharmaceutical and biotechnology companies, and the company claims 17 of the world's top 25 life science companies as customers, naming Pfizer, Genentech, Sanofi, Amgen, Teva, Novartis, Eli Lilly, Merck, and Bristol-Myers Squibb. The firm employs 51–100 people and has raised approximately $10.5M in disclosed venture funding across 2014–2020 from Excelerate Health Ventures, Hatteras Venture Partners, and Ariadne Capital, with no disclosed rounds since 2020.
The company positions itself against agencies (assets without outcome ownership), in-house teams (fragmented and unscaled), and CROs (execution-focused, education pushed downstream), claiming differentiated outcomes of a 3X increase in qualified patient referrals, a 40% improvement in randomization rates, and a 50% improvement in time to recruit. Its competitive positioning centers on treating patient readiness as a measurable, predictive operational variable rather than an assumed factor, with proprietary behavioral diagnostics, reusable content infrastructure, and accumulating trial-level data signals forming the basis of differentiation.
Jumo Health firmographics
Firmographics- Name
- Jumo Health
- Website
- https://JumoHealth.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Jumo Health is a Patient Experience Organization that sells CORE™ patient education content and the patent-pending PRISM™ readiness intelligence platform to biopharma sponsors and research partners, helping them improve clinical trial recruitment, enrollment, and completion.
- Ownership category
- akta.pro rank
Jumo Health industry classification
Industry- Product category
- Clinical Trial Patient Readiness Software
- NAICS
- Professional, Scientific, and Technical Services (541)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)
- akta.pro secondary industry
- Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
Keywords
Where Jumo Health is headquartered
LocationHeadquarters
- HQ city
- New Haven
- HQ country
- United States
- HQ region
- North America
Markets served
Jumo Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Enterprise Software Solutions: B2B SaaS model providing readiness solutions to biopharma sponsors and research partners. Solutions span the entire trial lifecycle and are offered as operational platforms across select therapeutic areas.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Jumo Health product offering
Product offeringCore offering
Jumo Health is a Patient Experience Organization that sells enterprise software (CORE™ and PRISM™) to biopharma sponsors and research partners to improve clinical trial recruitment, enrollment, and retention. CORE delivers expert-designed patient education content that translates protocols into human understanding, while PRISM is a patent-pending Patient Readiness & Intelligence System that uses conversational AI and behavioral diagnostics to assess, personalize, and govern patient readiness across the trial lifecycle.
Product overview
Jumo Health is a Patient Experience Organization offering two integrated solutions: CORE™ and PRISM™. CORE provides patient education content for recruitment and enrollment, while PRISM serves as a patient readiness and intelligence system that operates as infrastructure across the clinical trial lifecycle. Together, these products address different breakdown points—CORE focuses on immediate educational impact while PRISM provides a comprehensive operating system for measuring, predicting, and governing patient readiness from recruitment through trial completion.
Differentiator
Problem solved
Functional benefit
Brands
- CORE: Content for Recruitment & Education - delivers readiness through expertly designed patient education, translating protocols into human understanding and reducing fear, confusion and expectation mismatch.
- PRISM
Products and services
- CORE™ CORE (Content for Recruitment & Education) delivers patient readiness through expertly designed patient education content. It translates clinical protocols into human understanding so patients know what participation requires clinically, logistically, and emotionally before enrollment. CORE reduces fear, confusion, and expectation mismatch; supports patients and caregivers across the journey; and relieves site re-explanation burden. Best suited for complex, rare, pediatric, or high-burden trials needing immediate impact without system overhaul.
- PRISM™ (Patient Readiness & Intelligence System) PRISM is a patent-pending Patient Readiness & Intelligence System that governs readiness as infrastructure, turning patient experience into a measurable, predictive operational asset. It identifies eligible patients with high probability of activation, assesses cognitive readiness, personalizes education via conversational AI, governs advancement before failure occurs, and surfaces real-time readiness, risk, and completion signals. Designed for clinical operations leaders responsible for timelines, predictability, and cost-per-completer metrics.
Quantifiable outcome
- 3X increase in qualified patient referrals
- +2 more outcomes
Companies that use Jumo Health
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles3 records
Jumo Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
Jumo Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Areti HealthcoreStrategic partnership to advance Jumo Health's patent-pending PRISM system by integrating Areti Health's conversational and agentic AI delivery capabilities. The collaboration aims to support adaptive and governed patient interactions within regulated clinical environments. The goal is to address common trial challenges including screen failure after consent, early dropout, and protocol deviations by treating patient readiness as a governed, measurable execution variable. Both companies combine Jumo Health's clinical and behavioral expertise with Areti Health's AI technology to improve trial execution without disrupting existing sponsor, CRO, or site infrastructure.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Jumo Health competitors and assessment
Company assessmentDirect peers
- Antidote: Antidote operates a clinical trial patient recruitment and matching platform connecting sponsors with eligible patients. Direct comparable in patient recruitment and engagement for clinical trials, though Jumo Health differentiates on readiness depth rather than match-making.
- BBK Worldwide: BBK Worldwide is a patient recruitment and engagement agency for clinical trials offering technology-enabled patient enrollment solutions. Comparable to Jumo Health's CORE/PRISM combined offering focused on improving recruitment, enrollment, and retention outcomes.
- Clariness: Clariness provides global patient recruitment and engagement services for clinical trials, including feasibility, site support, and patient outreach. Directly comparable in addressing trial recruitment and retention pain points for biopharma sponsors.
- Curebase: Curebase is a decentralized clinical trial platform with built-in patient engagement, telemedicine, and remote data capture. Comparable in enabling trial participation outside traditional sites and improving patient experience across the trial lifecycle.
- Medable: Medable provides a decentralized and hybrid clinical trial platform with eCOA, eConsent, telehealth, and patient engagement modules. Directly comparable in enabling biopharma sponsors to run trials with greater patient-centric design and remote participation.
- Science 37: Science 37 operates a decentralized clinical trial operating system with patient recruitment, retention, and telemedicine-native workflows. Comparable as an enterprise patient engagement and trial-execution platform targeting biopharma sponsors.
Broad incumbents
- Veeva Systems: Veeva's Vault platform includes CTMS, eTMF, and clinical operations suites used across global biopharma. A broader incumbent that could extend into patient readiness as an adjacent capability, making it a strategic incumbent peer rather than direct competitor.
- IQVIA: IQVIA is a global CRO with extensive patient recruitment, site support, and real-world evidence offerings. A broad incumbent with overlapping capabilities in trial recruitment and operational execution, though readiness-specific depth differs from Jumo Health's positioning.
- Medidata (Dassault Systèmes): Medidata provides the Rave clinical trial platform (EDC, eCOA, randomization, trial management) used across most large biopharma sponsors. A broader incumbent whose platform expansion could incorporate readiness-adjacent features relevant to Jumo Health's market.
- WCG: WCG offers clinical trial optimization, site management, and patient engagement services to biopharma sponsors and CROs. A broad incumbent in clinical trial services with operational capabilities that overlap parts of Jumo Health's readiness-and-retention focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Jumo Health social profiles
Digital presenceJumo Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Jumo Health leadership team
Management profileNumber of profiles
Profiles4 records
Jumo Health funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Jumo Health M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Jumo Health
What does Jumo Health do?
Jumo Health is a Patient Experience Organization that sells enterprise software (CORE™ and PRISM™) to biopharma sponsors and research partners to improve clinical trial recruitment, enrollment, and retention. CORE delivers expert-designed patient education content that translates protocols into human understanding, while PRISM is a patent-pending Patient Readiness & Intelligence System that uses conversational AI and behavioral diagnostics to assess, personalize, and govern patient readiness across the trial lifecycle.
Is Jumo Health a public or private company?
Jumo Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Jumo Health founded?
Jumo Health was founded in 2009. It employs 51 to 100 people.
Where is Jumo Health based?
Jumo Health is headquartered in New Haven, United States, in the North America region.
How does Jumo Health make money?
One revenue line is on record: enterprise Software Solutions.
Who are Jumo Health's main competitors?
Direct peers on record are Antidote, BBK Worldwide, Clariness, Curebase, Medable and Science 37. Broad incumbents are Veeva Systems, IQVIA, Medidata (Dassault Systèmes) and WCG.
Does Jumo Health have an API?
No public API is recorded for Jumo Health.
What industry is Jumo Health in?
Jumo Health's product category is Clinical Trial Patient Readiness Software. Its primary akta.pro industry code is HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing), with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 541 and its SIC code is 8000.